Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR
Background: Antigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical performance data from large field studies is sparse. Methods: In a prospective performance evaluation study, RDT from three manufacturers (NADAL®, Panbio™, ME...
Uložené v:
| Vydané v: | EBioMedicine Ročník 69; s. 103455 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Elsevier B.V
01.07.2021
Elsevier |
| Predmet: | |
| ISSN: | 2352-3964, 2352-3964 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Background: Antigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical performance data from large field studies is sparse.
Methods: In a prospective performance evaluation study, RDT from three manufacturers (NADAL®, Panbio™, MEDsan®, conducted on different samples) were compared to quantitative reverse transcription polymerase chain reaction (RT-qPCR) in 5 068 oropharyngeal swabs for detection of SARS-CoV-2 in a hospital setting. Viral load was derived from standardised RT-qPCR Cycle threshold (Ct) values. The data collection period ranged from November 12, 2020 to February 28, 2021.
Findings: The sensitivity of RDT compared to RT-qPCR was 42·57% (95% CI 33·38%–52·31%). The specificity was 99·68% (95% CI 99·48%–99·80%). Sensitivity declined with decreasing viral load from 100% in samples with a deduced viral load of ≥108 SARS-CoV-2 RNA copies per ml to 8·82% in samples with a viral load lower than 104 SARS-CoV-2 RNA copies per ml. No significant differences in sensitivity or specificity could be observed between samples with and without spike protein variant B.1.1.7. The NPV in the study cohort was 98·84%; the PPV in persons with typical COVID-19 symptoms was 97·37%, and 28·57% in persons without or with atypical symptoms.
Interpretation: RDT are a reliable method to diagnose SARS-CoV-2 infection in persons with high viral load. RDT are a valuable addition to RT-qPCR testing, as they reliably detect infectious persons with high viral loads before RT-qPCR results are available.
German Federal Ministry for Education and Science (BMBF), Free State of Bavaria. |
|---|---|
| AbstractList | Background: Antigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical performance data from large field studies is sparse.
Methods: In a prospective performance evaluation study, RDT from three manufacturers (NADAL®, Panbio™, MEDsan®, conducted on different samples) were compared to quantitative reverse transcription polymerase chain reaction (RT-qPCR) in 5 068 oropharyngeal swabs for detection of SARS-CoV-2 in a hospital setting. Viral load was derived from standardised RT-qPCR Cycle threshold (Ct) values. The data collection period ranged from November 12, 2020 to February 28, 2021.
Findings: The sensitivity of RDT compared to RT-qPCR was 42·57% (95% CI 33·38%–52·31%). The specificity was 99·68% (95% CI 99·48%–99·80%). Sensitivity declined with decreasing viral load from 100% in samples with a deduced viral load of ≥108 SARS-CoV-2 RNA copies per ml to 8·82% in samples with a viral load lower than 104 SARS-CoV-2 RNA copies per ml. No significant differences in sensitivity or specificity could be observed between samples with and without spike protein variant B.1.1.7. The NPV in the study cohort was 98·84%; the PPV in persons with typical COVID-19 symptoms was 97·37%, and 28·57% in persons without or with atypical symptoms.
Interpretation: RDT are a reliable method to diagnose SARS-CoV-2 infection in persons with high viral load. RDT are a valuable addition to RT-qPCR testing, as they reliably detect infectious persons with high viral loads before RT-qPCR results are available.
German Federal Ministry for Education and Science (BMBF), Free State of Bavaria. Antigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical performance data from large field studies is sparse.BACKGROUNDAntigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical performance data from large field studies is sparse.In a prospective performance evaluation study, RDT from three manufacturers (NADAL®, Panbio™, MEDsan®, conducted on different samples) were compared to quantitative reverse transcription polymerase chain reaction (RT-qPCR) in 5 068 oropharyngeal swabs for detection of SARS-CoV-2 in a hospital setting. Viral load was derived from standardised RT-qPCR Cycle threshold (Ct) values. The data collection period ranged from November 12, 2020 to February 28, 2021.METHODSIn a prospective performance evaluation study, RDT from three manufacturers (NADAL®, Panbio™, MEDsan®, conducted on different samples) were compared to quantitative reverse transcription polymerase chain reaction (RT-qPCR) in 5 068 oropharyngeal swabs for detection of SARS-CoV-2 in a hospital setting. Viral load was derived from standardised RT-qPCR Cycle threshold (Ct) values. The data collection period ranged from November 12, 2020 to February 28, 2021.The sensitivity of RDT compared to RT-qPCR was 42·57% (95% CI 33·38%-52·31%). The specificity was 99·68% (95% CI 99·48%-99·80%). Sensitivity declined with decreasing viral load from 100% in samples with a deduced viral load of ≥108 SARS-CoV-2 RNA copies per ml to 8·82% in samples with a viral load lower than 104 SARS-CoV-2 RNA copies per ml. No significant differences in sensitivity or specificity could be observed between samples with and without spike protein variant B.1.1.7. The NPV in the study cohort was 98·84%; the PPV in persons with typical COVID-19 symptoms was 97·37%, and 28·57% in persons without or with atypical symptoms.FINDINGSThe sensitivity of RDT compared to RT-qPCR was 42·57% (95% CI 33·38%-52·31%). The specificity was 99·68% (95% CI 99·48%-99·80%). Sensitivity declined with decreasing viral load from 100% in samples with a deduced viral load of ≥108 SARS-CoV-2 RNA copies per ml to 8·82% in samples with a viral load lower than 104 SARS-CoV-2 RNA copies per ml. No significant differences in sensitivity or specificity could be observed between samples with and without spike protein variant B.1.1.7. The NPV in the study cohort was 98·84%; the PPV in persons with typical COVID-19 symptoms was 97·37%, and 28·57% in persons without or with atypical symptoms.RDT are a reliable method to diagnose SARS-CoV-2 infection in persons with high viral load. RDT are a valuable addition to RT-qPCR testing, as they reliably detect infectious persons with high viral loads before RT-qPCR results are available.INTERPRETATIONRDT are a reliable method to diagnose SARS-CoV-2 infection in persons with high viral load. RDT are a valuable addition to RT-qPCR testing, as they reliably detect infectious persons with high viral loads before RT-qPCR results are available.German Federal Ministry for Education and Science (BMBF), Free State of Bavaria.FUNDINGGerman Federal Ministry for Education and Science (BMBF), Free State of Bavaria. Background: Antigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical performance data from large field studies is sparse.Methods: In a prospective performance evaluation study, RDT from three manufacturers (NADAL®, Panbio™, MEDsan®, conducted on different samples) were compared to quantitative reverse transcription polymerase chain reaction (RT-qPCR) in 5 068 oropharyngeal swabs for detection of SARS-CoV-2 in a hospital setting. Viral load was derived from standardised RT-qPCR Cycle threshold (Ct) values. The data collection period ranged from November 12, 2020 to February 28, 2021.Findings: The sensitivity of RDT compared to RT-qPCR was 42·57% (95% CI 33·38%–52·31%). The specificity was 99·68% (95% CI 99·48%–99·80%). Sensitivity declined with decreasing viral load from 100% in samples with a deduced viral load of ≥108 SARS-CoV-2 RNA copies per ml to 8·82% in samples with a viral load lower than 104 SARS-CoV-2 RNA copies per ml. No significant differences in sensitivity or specificity could be observed between samples with and without spike protein variant B.1.1.7. The NPV in the study cohort was 98·84%; the PPV in persons with typical COVID-19 symptoms was 97·37%, and 28·57% in persons without or with atypical symptoms.Interpretation: RDT are a reliable method to diagnose SARS-CoV-2 infection in persons with high viral load. RDT are a valuable addition to RT-qPCR testing, as they reliably detect infectious persons with high viral loads before RT-qPCR results are available. AbstractBackground: Antigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical performance data from large field studies is sparse. Methods: In a prospective performance evaluation study, RDT from three manufacturers (NADAL®, Panbio™, MEDsan®, conducted on different samples) were compared to quantitative reverse transcription polymerase chain reaction (RT-qPCR) in 5 068 oropharyngeal swabs for detection of SARS-CoV-2 in a hospital setting. Viral load was derived from standardised RT-qPCR Cycle threshold (C t) values. The data collection period ranged from November 12, 2020 to February 28, 2021. Findings: The sensitivity of RDT compared to RT-qPCR was 42·57% (95% CI 33·38%–52·31%). The specificity was 99·68% (95% CI 99·48%–99·80%). Sensitivity declined with decreasing viral load from 100% in samples with a deduced viral load of ≥10 8 SARS-CoV-2 RNA copies per ml to 8·82% in samples with a viral load lower than 10 4 SARS-CoV-2 RNA copies per ml. No significant differences in sensitivity or specificity could be observed between samples with and without spike protein variant B.1.1.7. The NPV in the study cohort was 98·84%; the PPV in persons with typical COVID-19 symptoms was 97·37%, and 28·57% in persons without or with atypical symptoms. Interpretation: RDT are a reliable method to diagnose SARS-CoV-2 infection in persons with high viral load. RDT are a valuable addition to RT-qPCR testing, as they reliably detect infectious persons with high viral loads before RT-qPCR results are available. FundingGerman Federal Ministry for Education and Science (BMBF), Free State of Bavaria. |
| ArticleNumber | 103455 |
| Author | Rauschenberger, Vera Kurzai, Oliver Papsdorf, Michael Gawlik, Micha Forster, Johannes Weißbrich, Benedikt Petri, Nils Vogel, Ulrich Andres, Oliver Taurines, Regina Dölken, Lars Eisenmann, Michael Böhm, Hartmut Wagenhäuser, Isabell Krone, Manuel Liese, Johannes Knies, Kerstin Flemming, Sven Weismann, Dirk McDonogh, Miriam |
| Author_xml | – sequence: 1 givenname: Isabell surname: Wagenhäuser fullname: Wagenhäuser, Isabell organization: Institute for Hygiene and Microbiology, University of Wuerzburg, Josef-Schneider-Str. 2 / E1, Wuerzburg 97080, Germany – sequence: 2 givenname: Kerstin surname: Knies fullname: Knies, Kerstin organization: Institute for Virology and Immunobiology, University of Wuerzburg, Wuerzburg, Germany – sequence: 3 givenname: Vera surname: Rauschenberger fullname: Rauschenberger, Vera organization: Infection Control Unit, University Hospital Wuerzburg, Wuerzburg, Germany – sequence: 4 givenname: Michael surname: Eisenmann fullname: Eisenmann, Michael organization: Infection Control Unit, University Hospital Wuerzburg, Wuerzburg, Germany – sequence: 5 givenname: Miriam surname: McDonogh fullname: McDonogh, Miriam organization: Department of Orthopaedic Trauma, Hand, Plastic and Reconstructive Surgery, University Hospital Wuerzburg, Wuerzburg, Germany – sequence: 6 givenname: Nils surname: Petri fullname: Petri, Nils organization: Department of Internal Medicine I, University Hospital Wuerzburg, Wuerzburg, Germany – sequence: 7 givenname: Oliver orcidid: 0000-0002-1510-4051 surname: Andres fullname: Andres, Oliver organization: Department of Paediatrics, University Hospital Wuerzburg, Wuerzburg, Germany – sequence: 8 givenname: Sven orcidid: 0000-0002-6304-3169 surname: Flemming fullname: Flemming, Sven organization: Department of General, Visceral, Transplantation, Vascular and Paediatric Surgery, University Hospital Wuerzburg, Wuerzburg, Germany – sequence: 9 givenname: Micha surname: Gawlik fullname: Gawlik, Micha organization: Department of Psychiatry and Psychotherapy, University Hospital Wuerzburg, Wuerzburg, Germany – sequence: 10 givenname: Michael surname: Papsdorf fullname: Papsdorf, Michael organization: Department of Obstetrics and Gynaecology, University Hospital Wuerzburg, Wuerzburg, Germany – sequence: 11 givenname: Regina surname: Taurines fullname: Taurines, Regina organization: Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Wuerzburg, Wuerzburg, Germany – sequence: 12 givenname: Hartmut surname: Böhm fullname: Böhm, Hartmut organization: Department of Oral and Maxillofacial Surgery, University Hospital Wuerzburg, Wuerzburg, Germany – sequence: 13 givenname: Johannes surname: Forster fullname: Forster, Johannes organization: Institute for Hygiene and Microbiology, University of Wuerzburg, Josef-Schneider-Str. 2 / E1, Wuerzburg 97080, Germany – sequence: 14 givenname: Dirk surname: Weismann fullname: Weismann, Dirk organization: Department of Internal Medicine I, University Hospital Wuerzburg, Wuerzburg, Germany – sequence: 15 givenname: Benedikt surname: Weißbrich fullname: Weißbrich, Benedikt organization: Institute for Virology and Immunobiology, University of Wuerzburg, Wuerzburg, Germany – sequence: 16 givenname: Lars surname: Dölken fullname: Dölken, Lars organization: Institute for Virology and Immunobiology, University of Wuerzburg, Wuerzburg, Germany – sequence: 17 givenname: Johannes surname: Liese fullname: Liese, Johannes organization: Department of Paediatrics, University Hospital Wuerzburg, Wuerzburg, Germany – sequence: 18 givenname: Oliver surname: Kurzai fullname: Kurzai, Oliver organization: Institute for Hygiene and Microbiology, University of Wuerzburg, Josef-Schneider-Str. 2 / E1, Wuerzburg 97080, Germany – sequence: 19 givenname: Ulrich surname: Vogel fullname: Vogel, Ulrich organization: Institute for Hygiene and Microbiology, University of Wuerzburg, Josef-Schneider-Str. 2 / E1, Wuerzburg 97080, Germany – sequence: 20 givenname: Manuel orcidid: 0000-0002-1020-6454 surname: Krone fullname: Krone, Manuel email: krone_m@ukw.de organization: Institute for Hygiene and Microbiology, University of Wuerzburg, Josef-Schneider-Str. 2 / E1, Wuerzburg 97080, Germany |
| BookMark | eNqFkk1rGzEQhpeS0qRpfkEvOvayrr5W1lIaCKYfgUCLnfYqZGnWlbsrbaRdQ_59tbYpTaD4JDGa95nRvPO6OPPBQ1G8JXhGMBHvtzNYu9DNKKYkRxivqhfFBWUVLVkt-Nk_9_PiKqUtxphUPAflq-KccSIFr_FFkRat887oFvUQmxA77Q0g2Ol21IMLHoUGrW6Wq3IRfpYURd07i7Qf3AY8GiANzm-Q86gPzg9TstER0Jj0BqawCV2vo0sZNAS0vC8fvi-Wb4qXjW4TXB3Py-LH50_3i6_l3bcvt4ubu9IIXA-lyP-k1mILVoC0VFK2tkzLWkhpqKxNLRvMdQWaMMa10QIDNtauQVRzAjW7LG4PXBv0VvXRdTo-qqCd2gdC3CgdB2daUI3QmDNC5qKSXForJciGzues0vlmeGZdH1j9uO7AGvBD1O0T6NMX736pTdip3DWngmXAuyMghocxD051LhloW-0hjEnRiotaYsmmvtkh1cSQUoTmbxmC1eS-2qq9-2pyXx3cz6r6mcq4Ye9h7se1J7QfD1rIduwcRJWMg7wJ1kUwQ56XO6G_fqY3x7X6DY-QtmGMPjutiEpUYbWadnNaTUowplyKDPjwf8DJ8n8AXf707w |
| CitedBy_id | crossref_primary_10_1007_s11082_024_06798_6 crossref_primary_10_1038_s41598_022_15243_1 crossref_primary_10_1186_s12875_022_01756_1 crossref_primary_10_1016_j_ejmech_2023_115979 crossref_primary_10_1007_s00068_022_02091_x crossref_primary_10_1186_s12985_024_02459_y crossref_primary_10_1016_j_jcv_2022_105214 crossref_primary_10_1055_a_1937_9516 crossref_primary_10_1016_j_jinf_2022_12_017 crossref_primary_10_1038_s41467_021_27845_w crossref_primary_10_1088_1361_6528_ad67e8 crossref_primary_10_1016_j_jormas_2022_01_006 crossref_primary_10_1039_D5LC00343A crossref_primary_10_1038_s41598_024_52984_7 crossref_primary_10_1093_infdis_jiac198 crossref_primary_10_1016_j_cmi_2022_08_006 crossref_primary_10_1001_jamanetworkopen_2022_31798 crossref_primary_10_3390_diagnostics13183010 crossref_primary_10_1186_s12913_022_08511_3 crossref_primary_10_3389_fmed_2022_908127 crossref_primary_10_3390_diagnostics12061388 crossref_primary_10_1136_gutjnl_2022_327053 crossref_primary_10_1055_a_1916_9895 crossref_primary_10_1016_j_jcv_2022_105222 crossref_primary_10_1038_s41598_022_07447_2 crossref_primary_10_1016_j_heliyon_2023_e23518 crossref_primary_10_1177_2473974X211049328 crossref_primary_10_1021_jacs_1c08017 crossref_primary_10_1016_j_bios_2023_115800 crossref_primary_10_2196_35706 crossref_primary_10_3390_diagnostics12010110 crossref_primary_10_1007_s15010_022_01810_1 crossref_primary_10_5937_jomb0_35482 crossref_primary_10_1371_journal_pone_0268160 crossref_primary_10_1590_0037_8682_0016_2022 crossref_primary_10_1017_ash_2021_234 crossref_primary_10_1016_j_jviromet_2023_114811 crossref_primary_10_3389_fpubh_2023_1159622 crossref_primary_10_1128_spectrum_00763_21 crossref_primary_10_1038_s41598_023_48194_2 crossref_primary_10_1371_journal_pone_0278653 crossref_primary_10_1016_j_smhl_2024_100534 crossref_primary_10_1016_j_ebiom_2021_103491 crossref_primary_10_1016_j_ebiom_2024_105394 crossref_primary_10_7759_cureus_24173 crossref_primary_10_1016_j_puhe_2025_105903 crossref_primary_10_9778_cmajo_20210327 |
| Cites_doi | 10.1038/s41586-020-2196-x 10.1515/cclm-2021-0455 10.2807/1560-7917.ES.2021.26.1.2001365 10.1016/S2666-5247(21)00056-2 10.2807/1560-7917.ES.2020.25.3.2000045 10.1016/j.ebiom.2021.103230 10.1016/j.jcv.2021.104782 10.3390/jcm10020328 10.1214/ss/1009213286 10.1016/j.jinf.2020.12.033 10.1371/journal.pone.0248921 10.1016/j.cmi.2020.12.022 10.1001/jamaoto.2020.3579 10.1016/j.cmi.2020.11.004 10.15585/mmwr.mm7003e2 10.1016/j.eclinm.2020.100677 10.1016/j.jpeds.2021.01.027 10.1080/22221751.2020.1745095 10.3390/microorganisms9010058 10.1002/jmv.26770 10.1128/JCM.02338-20 |
| ContentType | Journal Article |
| Copyright | 2021 The Authors The Authors Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved. 2021 The Authors 2021 |
| Copyright_xml | – notice: 2021 The Authors – notice: The Authors – notice: Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved. – notice: 2021 The Authors 2021 |
| DBID | 6I. AAFTH AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.1016/j.ebiom.2021.103455 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2352-3964 |
| EndPage | 103455 |
| ExternalDocumentID | oai_doaj_org_article_f6a04311765848dd88e8f27735a8e8c4 PMC8234263 10_1016_j_ebiom_2021_103455 S2352396421002486 1_s2_0_S2352396421002486 |
| GroupedDBID | .1- .FO 0R~ 4.4 457 53G 5VS AAEDT AAEDW AAIKJ AALRI AAMRU AAXUO AAYWO ABMAC ACGFS ACVFH ADBBV ADCNI ADEZE ADRAZ ADVLN AEUPX AEXQZ AFPUW AFRHN AFTJW AGHFR AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BCNDV EBS EJD FDB GROUPED_DOAJ HYE HZ~ IPNFZ KQ8 M41 M48 O9- OK1 RIG ROL RPM SSZ Z5R 0SF 6I. AACTN AAFTH AFCTW NCXOZ AAYXX CITATION 7X8 5PM |
| ID | FETCH-LOGICAL-c609t-60162dd0ded6e8d2823bd3a89688c289c98f04a5ea1334aca60e0cddbe6571e93 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 62 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000677950600013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2352-3964 |
| IngestDate | Fri Oct 03 12:46:10 EDT 2025 Tue Nov 04 01:56:56 EST 2025 Fri Sep 05 13:12:03 EDT 2025 Thu Nov 13 04:14:06 EST 2025 Tue Nov 18 21:26:03 EST 2025 Tue Jul 25 20:59:50 EDT 2023 Sun Feb 23 10:19:36 EST 2025 Tue Aug 26 17:01:34 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Clinical evaluation Performance evaluation COVID-19 SARS-CoV-2 Antigen rapid diagnostic test PCR |
| Language | English |
| License | This is an open access article under the CC BY license. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c609t-60162dd0ded6e8d2823bd3a89688c289c98f04a5ea1334aca60e0cddbe6571e93 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0002-1510-4051 0000-0002-6304-3169 0000-0002-1020-6454 |
| OpenAccessLink | https://doaj.org/article/f6a04311765848dd88e8f27735a8e8c4 |
| PMID | 34186490 |
| PQID | 2546980839 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_f6a04311765848dd88e8f27735a8e8c4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8234263 proquest_miscellaneous_2546980839 crossref_primary_10_1016_j_ebiom_2021_103455 crossref_citationtrail_10_1016_j_ebiom_2021_103455 elsevier_sciencedirect_doi_10_1016_j_ebiom_2021_103455 elsevier_clinicalkeyesjournals_1_s2_0_S2352396421002486 elsevier_clinicalkey_doi_10_1016_j_ebiom_2021_103455 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-07-01 |
| PublicationDateYYYYMMDD | 2021-07-01 |
| PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationTitle | EBioMedicine |
| PublicationYear | 2021 |
| Publisher | Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier |
| References | Alemany, Baro, Ouchi (bib0013) 2021; 82 Torres, Poujois, Albert, Colomina, Navarro (bib0016) 2021; 27 Krüger, Leskien, Schuller (bib0001) 2021; 93 Bundesinstitut für Arzneimittel und Medizinprodukte: Antigen-Tests zum direkten Erregernachweis des Coronavirus SARS-CoV-2 Brown, Cai, DasGupta (bib0011) 2001; 16 2021. Bohn, Lippi, Horvath (bib0028) 2021 Richard-Greenblatt, Ziegler, Bromberg (bib0024) 2020 Galloway, Paul, MacCannell (bib0027) 2021; 70 Centers for Disease Control and Prevention (CDC): Interim Guidelines for collecting and handling of clinical specimens for COVID-19 testing Olearo, Nörz, Heinrich (bib0012) 2021; 137 Sullivan, Schwalje, Jensen (bib0025) 2020; 146 Corman, Bleicker, Schmidt (bib0018) 2021 Kohmer, Toptan, Pallas (bib0019) 2021; 10 Villaverde, Dominguez-Rodriguez, Sabrido (bib0021) 2021; 232 Bayerisches Landesamt für Statistik: Die Gliederung der Bevölkerung nach Kreisen sowie nach Alter, Geschlecht und nach Deutschen und Ausländern Young, Taylor, Cammarata (bib0004) 2020; 59 Corman, Landt, Kaiser (bib0002) 2020; 25 Berger, Ngo Nsoga, Perez-Rodriguez (bib0015) 2021; 16 European Centre for Disease Prevention and Control (ECDC): Diagnostic testing and screening for SARS-CoV-2 Stromer, Rose, Schafer (bib0020) 2020; 9 (bib0005) 2021 Avadhanula, Nicholson, Ferlic-Stark (bib0022) 2021 (Accessed 23 October 2020). Gremmels, Winkel, Schuurman (bib0017) 2021; 31 Loeffelholz, Tang (bib0003) 2020; 9 Vibholm, Nielsen, Pahus (bib0007) 2021; 64 (Accessed 3 March 2021). Krone, Noffz, Richter, Vogel, Schwab (bib0023) 2021; 26 Wölfel, Corman, Guggemos (bib0026) 2020; 581 (Accessed 17 February 2021). Albert, Torres, Bueno (bib0014) 2020; 27 Albert (10.1016/j.ebiom.2021.103455_bib0014) 2020; 27 Galloway (10.1016/j.ebiom.2021.103455_bib0027) 2021; 70 10.1016/j.ebiom.2021.103455_bib0006 Vibholm (10.1016/j.ebiom.2021.103455_bib0007) 2021; 64 Krone (10.1016/j.ebiom.2021.103455_bib0023) 2021; 26 Stromer (10.1016/j.ebiom.2021.103455_bib0020) 2020; 9 Richard-Greenblatt (10.1016/j.ebiom.2021.103455_bib0024) 2020 Villaverde (10.1016/j.ebiom.2021.103455_bib0021) 2021; 232 Wölfel (10.1016/j.ebiom.2021.103455_bib0026) 2020; 581 Olearo (10.1016/j.ebiom.2021.103455_bib0012) 2021; 137 Gremmels (10.1016/j.ebiom.2021.103455_bib0017) 2021; 31 Alemany (10.1016/j.ebiom.2021.103455_bib0013) 2021; 82 Bohn (10.1016/j.ebiom.2021.103455_bib0028) 2021 10.1016/j.ebiom.2021.103455_bib0009 Berger (10.1016/j.ebiom.2021.103455_bib0015) 2021; 16 Krüger (10.1016/j.ebiom.2021.103455_bib0001) 2021; 93 Sullivan (10.1016/j.ebiom.2021.103455_bib0025) 2020; 146 10.1016/j.ebiom.2021.103455_bib0008 10.1016/j.ebiom.2021.103455_bib0010 Kohmer (10.1016/j.ebiom.2021.103455_bib0019) 2021; 10 Avadhanula (10.1016/j.ebiom.2021.103455_bib0022) 2021 Corman (10.1016/j.ebiom.2021.103455_bib0018) 2021 Loeffelholz (10.1016/j.ebiom.2021.103455_bib0003) 2020; 9 Torres (10.1016/j.ebiom.2021.103455_bib0016) 2021; 27 Brown (10.1016/j.ebiom.2021.103455_bib0011) 2001; 16 Young (10.1016/j.ebiom.2021.103455_bib0004) 2020; 59 (10.1016/j.ebiom.2021.103455_bib0005) 2021 Corman (10.1016/j.ebiom.2021.103455_bib0002) 2020; 25 |
| References_xml | – volume: 9 start-page: 58 year: 2020 ident: bib0020 article-title: Performance of a point-of-care test for the rapid detection of SARS-CoV-2 antigen publication-title: Microorganisms – reference: Bundesinstitut für Arzneimittel und Medizinprodukte: Antigen-Tests zum direkten Erregernachweis des Coronavirus SARS-CoV-2, – volume: 26 year: 2021 ident: bib0023 article-title: Control of a COVID-19 outbreak in a nursing home by general screening and cohort isolation in Germany, March to May 2020 publication-title: Eurosurveillance – year: 2021 ident: bib0028 article-title: IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals publication-title: Clin Chem Lab Med – volume: 93 start-page: 28890 year: 2021 end-page: 28898 ident: bib0001 article-title: Performance and feasibility of universal PCR admission screening for SARS-CoV-2 in a German tertiary care hospital publication-title: J Med Virol – volume: 137 year: 2021 ident: bib0012 article-title: Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR publication-title: J Clin Virol – year: 2020 ident: bib0024 article-title: Impact of nasopharyngeal specimen quality on SARS-CoV-2 test sensitivity publication-title: MedRxiv – reference: (Accessed 17 February 2021). – year: 2021 ident: bib0022 article-title: Viral load of SARS-CoV-2 in adults during the first and second wave of COVID-19 pandemic in Houston, TX: the potential of the super-spreader publication-title: J Infect Dis – reference: (Accessed 23 October 2020). – year: 2021 ident: bib0005 article-title: COVID-19-Dashboard – volume: 27 year: 2021 ident: bib0016 article-title: Evaluation of a rapid antigen test (Panbio COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients publication-title: Clin Microbiol Infect – volume: 82 start-page: 186 year: 2021 end-page: 230 ident: bib0013 article-title: Analytical and clinical performance of the panbio COVID-19 antigen-detecting rapid diagnostic test publication-title: J Infect – volume: 146 start-page: 1179 year: 2020 end-page: 1181 ident: bib0025 article-title: Cerebrospinal fluid leak after nasal swab testing for coronavirus disease 2019 publication-title: JAMA Otolaryngol. Head Neck Surg – volume: 16 year: 2021 ident: bib0015 article-title: Diagnostic accuracy of two commercial SARS-CoV-2 Antigen-detecting rapid tests at the point of care in community-based testing centers publication-title: PLoS ONE – reference: 2021. – volume: 10 start-page: 328 year: 2021 ident: bib0019 article-title: The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity publication-title: J Clin Med – volume: 27 year: 2020 ident: bib0014 article-title: Field evaluation of a rapid antigen test (Panbio COVID-19 Ag rapid test device) for COVID-19 diagnosis in primary healthcare centres publication-title: Clin Microbiol Infect – volume: 16 start-page: 101 year: 2001 end-page: 133 ident: bib0011 article-title: Interval estimation for a binomial proportion publication-title: Stat Sci – volume: 31 year: 2021 ident: bib0017 article-title: Real-life validation of the Panbio COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection publication-title: EClinicalMedicine – volume: 70 start-page: 95 year: 2021 end-page: 99 ident: bib0027 article-title: Emergence of SARS-CoV-2 B.1.1.7 lineage - United States, December 29, 2020-January 12, 2021 publication-title: MMWR Morb Mortal Wkly Rep – volume: 232 start-page: 287 year: 2021 end-page: 289 ident: bib0021 article-title: Diagnostic accuracy of the panbio SARS-CoV-2 antigen rapid test compared with Rt-Pcr testing of nasopharyngeal samples in the pediatric population publication-title: J Pediatr – volume: 59 start-page: e02338 year: 2020 end-page: 20 ident: bib0004 article-title: Clinical evaluation of BD veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the sofia 2 SARS antigen point-of-care test publication-title: J Clin Microbiol – reference: European Centre for Disease Prevention and Control (ECDC): Diagnostic testing and screening for SARS-CoV-2, – volume: 25 year: 2020 ident: bib0002 article-title: Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR publication-title: Euro Surveill – reference: Centers for Disease Control and Prevention (CDC): Interim Guidelines for collecting and handling of clinical specimens for COVID-19 testing, – volume: 9 start-page: 747 year: 2020 end-page: 756 ident: bib0003 article-title: Laboratory diagnosis of emerging human coronavirus infections - the state of the art publication-title: Emerg Microbes Infect – reference: (Accessed 3 March 2021). – volume: 64 year: 2021 ident: bib0007 article-title: SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses publication-title: EBioMedicine – year: 2021 ident: bib0018 article-title: Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study publication-title: Lancet Microbe – reference: Bayerisches Landesamt für Statistik: Die Gliederung der Bevölkerung nach Kreisen sowie nach Alter, Geschlecht und nach Deutschen und Ausländern, – volume: 581 start-page: 465 year: 2020 end-page: 469 ident: bib0026 article-title: Virological assessment of hospitalized patients with COVID-2019 publication-title: Nature – volume: 581 start-page: 465 issue: 7809 year: 2020 ident: 10.1016/j.ebiom.2021.103455_bib0026 article-title: Virological assessment of hospitalized patients with COVID-2019 publication-title: Nature doi: 10.1038/s41586-020-2196-x – ident: 10.1016/j.ebiom.2021.103455_bib0009 – year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0028 article-title: IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2021-0455 – volume: 26 issue: 1 year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0023 article-title: Control of a COVID-19 outbreak in a nursing home by general screening and cohort isolation in Germany, March to May 2020 publication-title: Eurosurveillance doi: 10.2807/1560-7917.ES.2021.26.1.2001365 – year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0022 article-title: Viral load of SARS-CoV-2 in adults during the first and second wave of COVID-19 pandemic in Houston, TX: the potential of the super-spreader publication-title: J Infect Dis – year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0018 article-title: Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study publication-title: Lancet Microbe doi: 10.1016/S2666-5247(21)00056-2 – volume: 25 issue: 3 year: 2020 ident: 10.1016/j.ebiom.2021.103455_bib0002 article-title: Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR publication-title: Euro Surveill doi: 10.2807/1560-7917.ES.2020.25.3.2000045 – volume: 64 year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0007 article-title: SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses publication-title: EBioMedicine doi: 10.1016/j.ebiom.2021.103230 – volume: 137 year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0012 article-title: Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR publication-title: J Clin Virol doi: 10.1016/j.jcv.2021.104782 – volume: 10 start-page: 328 issue: 2 year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0019 article-title: The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity In Vitro publication-title: J Clin Med doi: 10.3390/jcm10020328 – year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0005 – volume: 16 start-page: 101 issue: 2 year: 2001 ident: 10.1016/j.ebiom.2021.103455_bib0011 article-title: Interval estimation for a binomial proportion publication-title: Stat Sci doi: 10.1214/ss/1009213286 – volume: 82 start-page: 186 issue: 5 year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0013 article-title: Analytical and clinical performance of the panbio COVID-19 antigen-detecting rapid diagnostic test publication-title: J Infect doi: 10.1016/j.jinf.2020.12.033 – volume: 16 issue: 3 year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0015 article-title: Diagnostic accuracy of two commercial SARS-CoV-2 Antigen-detecting rapid tests at the point of care in community-based testing centers publication-title: PLoS ONE doi: 10.1371/journal.pone.0248921 – volume: 27 issue: 4 year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0016 article-title: Evaluation of a rapid antigen test (Panbio COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.12.022 – volume: 146 start-page: 1179 issue: 12 year: 2020 ident: 10.1016/j.ebiom.2021.103455_bib0025 article-title: Cerebrospinal fluid leak after nasal swab testing for coronavirus disease 2019 publication-title: JAMA Otolaryngol. Head Neck Surg doi: 10.1001/jamaoto.2020.3579 – volume: 27 issue: 3 year: 2020 ident: 10.1016/j.ebiom.2021.103455_bib0014 article-title: Field evaluation of a rapid antigen test (Panbio COVID-19 Ag rapid test device) for COVID-19 diagnosis in primary healthcare centres publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2020.11.004 – volume: 70 start-page: 95 issue: 3 year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0027 article-title: Emergence of SARS-CoV-2 B.1.1.7 lineage - United States, December 29, 2020-January 12, 2021 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm7003e2 – volume: 31 year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0017 article-title: Real-life validation of the Panbio COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2020.100677 – ident: 10.1016/j.ebiom.2021.103455_bib0006 – ident: 10.1016/j.ebiom.2021.103455_bib0008 – volume: 232 start-page: 287 year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0021 article-title: Diagnostic accuracy of the panbio SARS-CoV-2 antigen rapid test compared with Rt-Pcr testing of nasopharyngeal samples in the pediatric population publication-title: J Pediatr doi: 10.1016/j.jpeds.2021.01.027 – year: 2020 ident: 10.1016/j.ebiom.2021.103455_bib0024 article-title: Impact of nasopharyngeal specimen quality on SARS-CoV-2 test sensitivity publication-title: MedRxiv – volume: 9 start-page: 747 issue: 1 year: 2020 ident: 10.1016/j.ebiom.2021.103455_bib0003 article-title: Laboratory diagnosis of emerging human coronavirus infections - the state of the art publication-title: Emerg Microbes Infect doi: 10.1080/22221751.2020.1745095 – ident: 10.1016/j.ebiom.2021.103455_bib0010 – volume: 9 start-page: 58 issue: 1 year: 2020 ident: 10.1016/j.ebiom.2021.103455_bib0020 article-title: Performance of a point-of-care test for the rapid detection of SARS-CoV-2 antigen publication-title: Microorganisms doi: 10.3390/microorganisms9010058 – volume: 93 start-page: 28890 issue: 5 year: 2021 ident: 10.1016/j.ebiom.2021.103455_bib0001 article-title: Performance and feasibility of universal PCR admission screening for SARS-CoV-2 in a German tertiary care hospital publication-title: J Med Virol doi: 10.1002/jmv.26770 – volume: 59 start-page: e02338 issue: 1 year: 2020 ident: 10.1016/j.ebiom.2021.103455_bib0004 article-title: Clinical evaluation of BD veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the sofia 2 SARS antigen point-of-care test publication-title: J Clin Microbiol doi: 10.1128/JCM.02338-20 |
| SSID | ssj0001542358 |
| Score | 2.4678855 |
| Snippet | Background: Antigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical performance data... AbstractBackground: Antigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical... Antigen rapid diagnostic tests (RDT) for SARS-CoV-2 are fast, broadly available, and inexpensive. Despite this, reliable clinical performance data from large... |
| SourceID | doaj pubmedcentral proquest crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 103455 |
| SubjectTerms | Advanced Basic Science Antigen rapid diagnostic test Clinical evaluation COVID-19 Internal Medicine PCR Performance evaluation Research Paper SARS-CoV-2 |
| Title | Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2352396421002486 https://www.clinicalkey.es/playcontent/1-s2.0-S2352396421002486 https://dx.doi.org/10.1016/j.ebiom.2021.103455 https://www.proquest.com/docview/2546980839 https://pubmed.ncbi.nlm.nih.gov/PMC8234263 https://doaj.org/article/f6a04311765848dd88e8f27735a8e8c4 |
| Volume | 69 |
| WOSCitedRecordID | wos000677950600013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2352-3964 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001542358 issn: 2352-3964 databaseCode: DOA dateStart: 20140101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA96KPgifuL6cUTw0WCbtmnyeC4ePshx7J7HvoU0SbVytHvbruB_70za7rUgdy--lTRpw8x08hs68xtCPggHTs7ynKnSWQaIOGbS24zFPHLSJVYlIdv98lt-diY3G3U-afWFOWE9PXAvuE-lMMj_Eud4VErnpPSy5HmeZAaubGACBdQzCab6-uAUa0BDZ7mMs0SJdKQcCsldHovbITrkMVadp1joNzmWAnv_7HSaoM957uTkMDp9Qh4PKJKe9Lt_Su75-hl52PeV_POctAPb5xXd3tQF0Btib9qUdH2yWrNlc8k43Zlt5SiIGJk5aYe8G_UPWtV021R1h5MxP4zuMQcNh-2hdyHtGrq6YNfny9UL8v30y8XyKxu6KzArItUx5GHhzkXOO-Glg9ArKVxipBJSWgjDrJJllJrMGwhjU2ONiHxknSu8yPLYq-QlOaqb2r8iNCkyV0Bk6KzkaQmgwwsOMEQZXiKALBaEj8LVdqAexw4YV3rMMfulg0Y0akT3GlmQj4dF25554_bpn1Frh6lImx0GwJj0YEz6LmNakHTUuR4rU8GXwoOq29-d_2uZbwd_0OpYt1xHeo3WiMbI40AmJxZEHFYOkKeHMne_8v1okhocAv7lMbVv9q3GBgdKArJWsK2Zrc5kM79TVz8DtTgYATL4v_4fwnxDHuGG-9zmt-So2-39O_LA_u6qdndM7ucbeRy-2r97hkK2 |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+performance+evaluation+of+SARS-CoV-2+rapid+antigen+testing+in+point+of+care+usage+in+comparison+to+RT-qPCR&rft.jtitle=EBioMedicine&rft.au=Wagenh%C3%A4user%2C+Isabell&rft.au=Knies%2C+Kerstin&rft.au=Rauschenberger%2C+Vera&rft.au=Eisenmann%2C+Michael&rft.date=2021-07-01&rft.pub=Elsevier+B.V&rft.issn=2352-3964&rft.eissn=2352-3964&rft.volume=69&rft_id=info:doi/10.1016%2Fj.ebiom.2021.103455&rft.externalDocID=S2352396421002486 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F23523964%2FS2352396421X00072%2Fcov150h.gif |